Glenmark Pharma stock falls on stake sale in Glenmark Life Sciences

| Leave a Comment | Stocks

Glenmark Pharmaceuticals share price fell 2 percent at open on September 22, after the pharma company agreed to divest 75 percent of its stake in subsidiary Glenmark Life Sciences to Nirma.

Glenmark Pharma will own 7.84 percent in Glenmark Life Sciences, down from the current 82.9 percent, after the sale. Nirma will have to make a mandatory open offer to public shareholders of Glenmark Lifesciences for an additional 17.15 percent stake at Rs 631 a share.

Analysts expect Glenmark to benefit from the stake sale, as it will transition from a net debt position to a cash surplus position. This is expected to have a positive impact on the company’s return ratios over the next two to three years.

Glenmark Pharma’s management has said that they aim to be net cash positive for the next two years after the total debt gets extinguished after the deal. Going forward, they will focus on growth, ROCE, and being cash positive.


Related News

  • 22 Sep

    NBCC shares trade higher on Rs 100 crore work order from SAIL

    NBCC shares were trading 3 percent higher on September 22 after the company announced having bagged a work order worth Rs 100 crore from SAIL. This is the fourth order-win announced by the company in this month, the total value of the same being Rs 450 crore. NBCC is a public sector undertaking engaged in the business of construction and real estate development. The company specializes in providing project management, consultancy and engineering services for civil construction, infrastructure development, and real estate projects.

  • 22 Sep

    Berger Paints Shares Hit 52-Week High After Turning Ex-Bonus

    Berger Paints shares surged 6% to hit a 52-week high after turning ex-bonus on the record date for the issue of bonus shares in the ratio 1:5. The company posted a net profit of Rs 326.3 crore in the April-June quarter of FY24, up 39% year-on-year, on revenue of Rs 2,739.7 crore, up 10% year-on-year. The company expects to get net cash positive by the end of this fiscal year and expects to end the year with double-digit revenue growth on strong demand outlook.

  • 22 Sep

    Market Update for September 22, 2023

    IdeaForge Tech up 3.4% on order RVNL up 3% on highway MoU JSW Steel up 0.4% on sale ICICI Lombard down 1.6% on CEO exit ICICI Bank down 1% on healthcare investment NHPC up 1.3% on extended additional charge Kalyani Forge up 3.2% on new MD IRB Infra up 2.5% on road project closure

  • 22 Sep

    Lux Industries Shares Down 3% After Income Tax Raid

    Lux Industries shares fell 3% on September 22 after news emerged that the Income Tax department had conducted searches at the company's premises in Kolkata and alleged a tax evasion of Rs 200 crore. The company has confirmed the searches and is extending full support.

  • 22 Sep

    HDFCB Clarifies on Merged Financials

    HDFCB has clarified certain aspects relating to merged financials, which are likely to have a mixed impact on the company's performance in the near term. However, the outlook for HDFCB remains positive in the medium to long term, with core earnings growth expected to revive.

Leave a Reply

Your email address will not be published. Required fields are marked *